The World Health Organization has released its much-awaited guidance on best practices for clinical trials, which addresses challenges such as poor trial design, limited diversity of participants, insufficient infrastructure and bureaucratic efficiencies that cost time, money and lives.
Key Takeaways
-
The WHO has issued new guidance to improve the design, conduct and oversight of clinical trials in countries of all income levels.
-
The guidance addresses a raft of issues affecting the current clinical trials landscape, such as limited participant diversity, insufficient infrastructure and bureaucratic inefficiencies.
-
The WHO document builds on existing clinical trial guidelines, such as those issued by the International Council for Harmonisation, the Council for International Organizations of Medical Sciences and the Good Clinical Trials Collaborative
The 76-page
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?